0.00Open1.20Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover5592.24%IV0.54%PremiumMay 17, 2024Expiry Date1.18Intrinsic Value100Multiplier-5DDays to Expiry0.02Time Value100Contract SizeAmericanOptions Type0.8431Delta0.1533Gamma3.07Leverage Ratio-8.3185Theta0.0000Rho2.58Eff Leverage0.0001Vega
NRX Pharmaceuticals Stock Discussion
Catching the attention of the pharmaceutical industry and investors alike, NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced final clinical trial results showcasing a superior safety profile of NRX-101 over lurasidon...
NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Final Clinical Trial Results: Superior Safety Combined With Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
No comment yet